Objectives: The purpose of the study was to develop a population-based simulation model of osteoarthritis (OA) in Canada that can be used to quantify the future health and economic burden of OA under a range of scenarios for changes in the OA risk factors and treatments. In this article we describe the overall structure of the model, sources of data, derivation of key input parameters for the epidemiological component of the model, and preliminary validation studies.
Introduction
Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability 1, 2 . As the population ages, the number of persons suffering from OA is expected to increase 3e6 . A number of strategies have been advocated to reduce the burden of OA 7e11 . However, quantification of the potential impact of such strategies on future disease burden is a complex undertaking. The effects of important risk factors for OA, such as age and overweight/obesity, are nonlinear and the distribution of both factors in the population is changing 2, 12, 13 . Similarly, extrapolating the benefits and side-effects of interventions from randomized trials to a population setting is not straightforward as one has to consider the existing treatment patterns, heterogeneity of effects, as well as changes in the demographic structure of the population 14 . Because of such complexities, standard economic and policy analyses of OA burden typically make simplifying assumptions about the population under study and the impact of interventions over time 15, 16 . Simulation modeling of disease processes in a population can inform health policy and has consequently become increasingly accepted and adopted 17 . Recent developments in modeling technology include microsimulation, continuoustime models, and advances in model calibration 18 . An important distinction is between macrolevel (group-based) models and microsimulation. In macrolevel models, groups of individuals move through several stages based on transition probabilities and the summary measures of interest are calculated. In contrast, microsimulation models simulate individual life histories, with the timing of events determined stochastically 19 . The main advantages of microsimulation include a potentially infinite number of events and stages in disease process that can be modeled and flexibility in defining input populations, merging multiple data sources, taking into account heterogeneity of effects, and implementing changes in the model 18e21 .
Thanks to a dramatic progress in computer technology it is now possible to perform the calculations needed to simulate millions of individual life histories 18 . Complex population-level processes can be described by a series of relatively simple equations and probabilistic parameters at the level of the individual. The model integrates such individual-level data and translates them into projections of disease burden in the population. By changing the input parameters, such as the distribution of disease risk factors and comparing the likely outcomes, it is possible to evaluate various interventions in terms of their expected impact on disease incidence, prevalence, mortality, quality-adjusted life years (QALYs), and costs 17e19 . Although simulation models have been used in arthritis research for cost-effectiveness and decision analyses 22e27 , none of these models has been based on generating individual life histories in a population or included a primary prevention component.
The purpose of the study was to develop a simulation model of OA in a Canadian population that can be used to quantify the future health and economic burden of OA under a range of plausible scenarios for changes in the risk factors and treatments. In this article we provide an overview of the model development process, with a focus on OA incidence and its impact on quality of life. Modeling of the impact of OA treatment (both surgical and non-surgical) and economic aspects of OA will be presented in separate publications. The following stages in model development are described: (1) conceptualization of the disease; (2) implementation of a computer simulation program; (3) derivation of the model parameters; and (4) model calibration and validation. The key assumptions and limitations of the model are discussed.
Methods

CONCEPTUAL FRAMEWORK
POHEM-OA is a population-based simulation model. The disease is defined as physician-diagnosed OA of any site, as opposed to radiographic or clinical OA. Population-level data on radiographically or clinically defined OA of specific joints are not available in Canada. Furthermore, this is an incidence-driven model e the key parameter is OA incidence (hazard) rate. The incidence rate is modeled as a function of established risk factors for OA, allowing for non-linear dose-response relationships and effect modification. Trends in OA incidence are determined by changes in the distribution of risk factors in the population over time. The burden of OA can be expressed in terms of the number of cases and impact on health-related quality of life (HRQL). The key components of the model and relationships between them are presented in Fig. 1 . Main model parameters, methods of derivation, and data sources are listed in Table I . Baseline population data and technical details are provided in the Appendix.
SIMULATION PLATFORM
Simulations are performed using the Population Health Model (POHEM) platform 28 . POHEM is a generic, continuous-time microsimulation environment developed at Statistics Canada 29 . The unit of simulation is the individual and the events can occur at arbitrarily small time intervals. This modeling approach differs from group-based methods of modeling proportions and classic Markov models which assume constant transition rates between prespecified states 30, 31 . POHEM generates individual life trajectories within a large population representative of Canada, one individual at a time, until death. The stochastic nature of POHEM means that replicated lives with identical initial conditions have different life trajectories, because they have a different stream of random numbers used in their decision path. POHEM has been validated and used to assess the impact of prevention strategies, treatments, and cost of care in breast, lung, and colorectal cancer 32e38 .
PARAMETERS AND SOURCES OF DATA
Age and gender POHEM-OA uses the 2001 Canadian Community Health Survey (CCHS) sample as the baseline population 39 . The CCHS is a cross-sectional survey conducted every 2 years, with a total national sample of 130,000. The CCHS target population includes persons age 12þ, living in households in the 10 Canadian provinces, with the exception of Indian reserves, military bases, and some remote northern areas. POHEM-OA includes subjects 18 years of age or older. Each subject from the CCHS sample is replicated at time of initialization to reflect its survey sample weight. Consequently, approximately 25 million individual lives, reflecting the non-institutionalized adult Canadian population, are simulated in a single run. Since POHEM-OA simulates a dynamic population, subjects are removed from the population as a result of death and new subjects are added to the population by aging into it (on their 18th birthday). To simulate these events, death and birth rates by age and sex were obtained from the national vital statistics and census databases routinely used by Statistics Canada for demographic projections 40 .
Body mass index (BMI)
At the population level, the most important modifiable risk factor for OA is BMI 2, 12, 41 . The distribution of BMI in the baseline population was obtained directly from the CCHS, based on the formula BMI ¼ weight/height 2 (Table I) . Individual BMI trajectories were simulated using a regression model based on longitudinal data from the National Population Health Survey (NPHS) in Canada 42 . The NPHS started in 1994 with a random household population sample of about 20,000, with a sampling frame similar to that of the CCHS. These subjects are followed every 2 years 43 . The model to simulate BMI used data from 1996 to 2004 and included age, sex, province of residence, education, income, and prior BMI.
OA incidence
In POHEM-OA, OA incidence at the start of simulation is adjusted to reflect the incidence of physician-diagnosed OA in Canada. This adjustment, referred to as calibration, uses age/sex-specific incidence rates for 2003/4 (the last year for which data were available), derived from the British Columbia Linked Health Database (BCLHD) ( Table I ). The BCLHD is a well-established administrative database in the province of British Columbia, Canada that has been used extensively for research purposes 44 . It contains data on physician billings in the publicly funded health care system covering >95% of the population. The methodology for estimating incidence rates of OA from administrative data has been described elsewhere 45 . The definition of OA required either two physician visits within 2 years of each other or one hospitalization with the ICD-9 code 715 (Osteoathrosis and allied disorders) or the corresponding ICD-10 codes. To obtain incidence rates for Canada, age/sex-specific BC rates were applied to the age/sex distribution of the Canadian population.
OA prevalence
As not all individuals with diagnosed OA seek regular medical care for their condition 46 , age/sex-specific prevalence proportions of OA from an administrative database may underestimate the true prevalence, particularly if the run-in time is too short 45 . To ensure consistency between incidence and prevalence data, we simulated OA prevalence in the Canadian population over a long period of time (up to 50 years) while keeping the incidence rates constant at the most recent level. The age/sex-specific prevalence proportions obtained from this simulation were applied to the baseline CCHS population to obtain the distribution of OA at baseline 47 .
Effect of BMI
When simulating the occurrence of OA in individuals, the age/sex-specific hazard rates are modified according to the person's BMI. The effect of BMI on OA risk has been estimated using longitudinal data from the two cycles of the NPHS (2000 and 2002) that asked the question on any self-reported physician-diagnosed OA and were available for analysis. To this end, we have fit a multivariable survival regression model. The effect of BMI is expressed as hazard ratios for underweight (BMI < 18.5), overweight (BMI 25.0e29.9) and obesity (BMI 30þ), compared to normal BMI (18.5e24.9). The effects were estimated separately for males and females and adjusted for age (Table I) . Baseline prevalence of OA by age and sex Obtained as the final stable prevalence from a simulation of the Canadian population over a 50-year time horizon, under constant age/sex-specific, BCLHD-based incidence rates.
Mortality rates by age and sex over time Based on mortality data and using Statistics Canada projections of mortality for Canada.
Baseline incidence rates of OA by age and sex Obtained from BCLHD. OA was defined as at least two visits to a health professional within 2 years or one hospitalization with the International Classification of Diseases, Ninth Revision (ICD-9) code 715. Incident cases were identified after excluding prevalent cases, using a 12-year run-in period.
Reference incidence rates of OA (for persons with normal BMI) by age and sex
Obtained numerically using an iterative algorithm (calibration). These rates are based on the incidence rates from BCLHD and the distribution of BMI levels in the CCHS population, within age/sex groups. 48 . The attributes are combined into an overall index, ranging from À0.36 to 1, using a multi-attribute utility theory model based on societal preferences. Therefore, HUI3 can be employed to estimate QALY. The initial distribution of HUI3 in POHEM-OA is obtained directly from the CCHS. Individual HUI3 trajectories were simulated with a tobit regression model (accounting for the skewed distribution of HUI3 scores) that included age, gender, BMI, and OA status 49 . The model was derived from the 2001 cycle of the CCHS (Table I) . Model fit was evaluated by the likelihood ratio test and a comparison of the scale parameter, which estimates the standard deviation of the normal error term, between the reduced and saturated model.
MODEL CALIBRATION AND VALIDATION
The population modeled by POHEM-OA reflects the Canadian adult household population surveyed by the CCHS. As the model simulates individual life histories, the risk of OA is influenced by individual BMI values according to the relative risk derived from the NPHS. In order that the aggregated age/sex-specific incidence rates in the simulated population correspond to the observed population rates in administrative data, given the population distribution of BMI, the age/sex-specific rates for the reference BMI category need to be estimated. This was achieved through model calibration, whereby the reference rates were iteratively adjusted using numerical methods until the simulated and observed incidence rates (within age/ sex categories) agreed 18, 19 . The population distribution by age from 2001 to 2007 in POHEM-OA has been compared to the actual Canadian population-based on estimates from the 2001 and 2006 censuses. To validate the simulated OA frequency, we compared the incidence and prevalence of OA in POHEM-OA with self-reported incidence of arthritis and rheumatism in the NPHS, self-reported OA prevalence in the CCHS and BCLHD, and clinical and radiographic OA incidence and prevalence from the literature 45, 47, 50, 51 . We also assessed the effects of OA definition and run-in time on the incidence and prevalence of OA in administrative data 45 . In addition, we have estimated the sensitivity and specificity of the administrative definition of OA by linking the BCLHD to a population-based cohort study of 171 subjects with extensive clinical and radiographic data 52 . Finally, our model for predicting HUI3 in the general population has been validated by comparing the predicted and observed HUI3 scores in a different cycle of the CCHS.
Results
POHEM-OA has a large number of parameters, including descriptive parameters, such as age and sex distribution at baseline, birth and death rates by age, sex, and year, education and income distribution, age/sex-specific OA prevalence proportions at baseline, age/sex-specific OA incidence rates, and other parameters. In this article we discuss the key input parameters related to the frequency and health impact of OA (Table I ).
In Fig. 2 , we compare the simulated age distribution in POHEM-OA in 2007 with the distribution estimated from the 2006 census. The data show a nearly perfect correspondence between the two datasets. Minor discrepancies are mainly due to the exclusion of the institutionalized populations in the CCHS and differences between the weights developed for the CCHS in 2001 and the revised census estimates.
Age/sex-specific incidence rates of physician-diagnosed OA in POHEM-OA are presented in Table II . The rates increase approximately linearly with age in both sexes between the ages of 50 and 80 and plateau in the very old. In persons 50þ, women have substantially higher rates than men, with the male-to-female ratio between 0.6 and 0.7 in most age groups. The baseline prevalence of OA generated from the POHEM-OA simulation is 11.5%, 13.6% in women and 9.3% in men.
In Table III we provide the age-adjusted OA hazard ratios for the different BMI categories, separately for men and women. Since the main purpose of this analysis was to provide the input parameters for the simulation model, confidence intervals are not reported. The effect of BMI is stronger in women, with the hazard ratios of 1.76 and 2.03 for BMI 25e29.9 and 30þ, respectively, compared to normal weight (BMI between 18.5 and 24.9). The corresponding hazard ratios for men are 1.07 and 1.69. Rates are decreased for men and women with BMI < 18.5 (in our sample there were no cases of OA among men with BMI < 18.5). 
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In POHEM-OA, HRQL (measured by HUI3) is predicted by OA, age, sex and BMI, using a tobit model 49 (Table IV) . The effects of OA and BMI on HUI3 were different in men and women. This difference in effects is captured by the interactions between BMI and sex and between OA and sex that were highly significant. The average impact of OA diagnosis is to decrease HUI3 score by 0.10 in women and 0.14 in men. Age has a negative effect on HUI3 and women have, on average, lower HUI3 scores than men. Model fit was adequate, as suggested by the estimated error term which was very similar in the reduced and saturated models (data not shown). The likelihood ratio test was significant, indicating that additional interaction terms might improve the fit of the model, but this test is less informative when the sample size is very large.
Discussion
This article describes the methodology and key parameters for a population-based simulation model of OA in Canada, with a focus on OA incidence and its impact on quality of life. Most of the input parameters have been derived from the Canadian Census and vital statistics databases, national surveys, administrative data in British Columbia, and the health literature. Advanced statistical methods have been used to derive time-to-event distributions and the relationships between the variables. Model calibration ensures that the simulated incidence rates agree with the observed rates.
The model uses the POHEM platform, a state-of-the-art microsimulation tool that can simulate a dynamic population as it changes over time, as opposed to modeling a fixed cohort or a stationary population. Events are modeled in continuous time and there is no limit on the number of events that can be simulated. An important feature of POHEM-OA is the transparency of the model. The structure of the model, parameter values, and sources of data are publicly available. Assumptions and limitations of the model are acknowledged and discussed.
OA incidence rates in POHEM-OA are higher than those estimated by Oliveria et al. for radiographic and symptomatic OA of the knee, hip and hand, derived from an administrative database in the US 50 . This is epidemiologically plausible since our definition included all OA sites and did not require radiographic confirmation. At the same time, our rates are lower than published incidence rates of self-reported ''arthritis or rheumatism'' in Canada 51 . Direct comparisons between the clinical and administrative diagnosis of OA are scarce. Harrold et al. 53 found a positive predictive value of 62% in the US using medical records as a gold standard. In our previous validation study, the administrative definition of OA had sensitivity around 30% and specificity over 90% against a diagnosis based on clinical and radiographic criteria 52 . The simulation-derived estimates of baseline OA prevalence in POHEM-OA are higher than those directly obtained from administrative data 45 . The most likely reason is the tendency for administrative data to underestimate OA prevalence due to insufficient run-in time. This tendency has been previously demonstrated in our database 45 . Our estimates of baseline prevalence are consistent with the most recent incidence rates observed in the data. Although our previous study using the BC database suggested an increase in age-standardized incidence rates of OA among women between 1996 and 2003, data on long-term trends in OA incidence are not available 3 . For this reason, and to simplify the analysis, we assumed that the age/sexspecific incidence rates in the past were constant. Baseline prevalence in our model is overestimated if the incidence rates were lower prior to baseline (i.e., if there was an increasing trend), and underestimated if the incidence rates were higher, but the difference is very unlikely to be substantial.
The risk of developing OA in POHEM-OA is determined by age, gender and BMI. The effect of BMI on the OA incidence rate was estimated from a longitudinal population survey in Canada using self-reported physician-diagnosed OA. Comparative data for a similar definition of OA are not available. In a study of radiographic knee OA by Felson et al. 41 in the Framingham cohort, the age-adjusted odds ratios in the highest and second highest quintiles of height-adjusted weight were 2.07 and 1.44, respectively, for women, and 1.51 and 1.00, respectively, for men. Given the differences in definitions and methodology between the two studies, the results are remarkably similar to the hazard ratios from our model (Table III) .
The effects of age, sex and OA on HUI3 were estimated from the CCHS, a large national survey in Canada. Comparative population data for a similar definition of OA are not available. Schultz and Kopec 54 previously estimated the overall effect of ''arthritis and rheumatism'' on HUI3 at À0.09 using data from the 1996/7 NPHS and adjusting for co-morbidity. Similar to the current study, the effect was stronger in men. In a graphical analysis, our model predicted HUI3 scores observed in a different CCHS cycle with acceptable accuracy (data not shown).
While the results of preliminary validation are promising, there is a need for more validation studies. Future validation will include re-evaluation of the current input parameters, comparisons of model output with the actual trends observed in administrative and survey data from several Canadian provinces, and stochastic sensitivity analyses.
The definition of OA adopted in our model is useful from a healthcare utilization perspective but it has clear limitations. Our model is unable to distinguish between different OA sites, which limits its ability to model heterogeneous effect of risk factors on OA incidence. In terms of modeling the impact of OA on quality of life, many cases of symptomatic or even disabling OA remain undiagnosed. The effect of our OA definition on the estimates of disease burden in 
0.00
0.00 HUI3 ¼ Health Utilities Index Mark 3.
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POHEM-OA will be evaluated in a sensitivity analysis. Modeling joint pain and other symptoms in the population, as opposed to physician-diagnosed OA, might be a potentially useful alternative in future studies.
We acknowledge that the values of the specific parameters in POHEM-OA are potentially subject to criticism and may need to be modified as new and better data become available. Different studies may produce different estimates of the incidence, prevalence, relative risk, or health impact of OA. A limitation of the current version of POHEM-OA is that it does not include other factors that may potentially affect the incidence of OA, such as geographic region, race, socio-economic status, injury, physical activity, or family history of OA 2 . Data on the distribution of these factors in the population, changes over time, and causal effects on the risk of OA are insufficient at this time. Projections of disease incidence and prevalence from our model may be inaccurate if there are temporal changes in the distribution of these factors, as well as other and unknown risk factors for OA. This limitation can be minimized by introducing a correction for trend in incidence rates based on historical data. Furthermore, the effect of BMI on OA incidence in the model is derived from data on self-reported physiciandiagnosed OA of any joint. While this effect may be attenuated due to unavoidable misclassification of the disease, it is based on the best Canadian data currently available.
At present, POHEM-OA does not contain any parameters describing the effects of specific interventions on changes in health behaviors, such as diet or healthcare utilization, in different population groups. Implementing such parameters would allow a more realistic simulation of the impact of health policies across various segments of the population. Although the available data are limited, we intend to incorporate behavioral effects into future versions of the model.
Despite its limitations, the current model can inform policy by providing information not directly available from epidemiological studies. Its main purpose is to study the effects of changes in the distribution of risk factors for OA on the future burden of this disease in a dynamically changing population. Current policy analyses typically make simplifying assumptions about the population under study and the effects of health interventions at the population level 15, 16 . In particular, standard methods of calculating attributable fraction usually assume that the risk factor is eliminated and that the underlying population is static. In addition, such methods generally do not consider the impact of disease on quality of life 14 . The current model can be used to project the future burden of OA in Canada while taking into account trends in population aging and obesity prevalence. For example, we have recently applied the model to compare different scenarios for future OA incidence rates in terms of their impact on healthadjusted life expectancy (HALE) in Canada 55 . Preliminary results show that if new cases of OA due to excess weight could be avoided, average HALE would improve by 2e4 months and the gain would be somewhat greater in women. Another example is the use of the model to analyze the relative contributions of aging and obesity to the projected increase in the number of persons with OA 56 . In conclusion, we have developed the first populationbased microsimulation model of OA. We hope the model will provide a benchmark for the synthesis of quantitative data on the epidemiology and population health impact of OA. We expect to be able to improve the model as gaps in knowledge are addressed in future studies. While the initial results from this model will have to be taken with caution, the confidence in the results will increase as the validity of the model is further confirmed under a variety of conditions.
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Population parameters
Tables A1eA7 shows the distribution of key POHEM-OA variables in the CCHS. These tables include all CCHS respondents. Weighted data reflect the distribution in the Canadian household population. Data in Tables A8eA10 are  shown for illustration purposes. The estimates are rounded and shown for selected ages and/or years only. When running POHEM, more precise estimates for all ages and years are used. The following steps describe the basic algorithm for determining when OA occurs in the microsimulation:
(1) POHEM selects a record from the CCHS database in the simulation start year (2001).
(2) At each birthday in the person's simulated life, annualized hazard h is calculated as: h ¼ h 0 Â RR. In this equation h 0 is the age/sex-specific OA incidence rate for persons with normal BMI estimated from BCLHD rates using calibration methods (Table A9 in the Appendix), and RR is the relative risk (hazard ratio) of OA based on person's BMI category (Table III in The BMI model is part of the POHEM software and was developed by Statistics Canada using biannual data from the longitudinal NPHS 1996e2004. The model predicts current BMI within 14 groups defined by BMI category and age, separately for men and women, based on BMI history and other covariates, such as region of residence, income and education. The response variable is change in BMI compared to 2 years prior, treated as a continuous, normally distributed variable. The model includes the most recent BMI value and up to three prior changes in BMI. The model can be presented in a simplified form as:
In this equation, DBMI i;j ¼ BMI j À BMI i is the difference in BMI between time i and time j.
There are 112 regression equations arising from 28 strata (modeling groups) generated by the 14 age Â BMI categories and the sex variable (male and female). Within each stratum, there are four models, depending on the number of prior BMI values used.
